Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001846478-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-07 | 2025-03-05 | ANIP | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | +300 | 99.5K | +0.3% | +$9,447 |
| DM | 2025-03-07 | 2025-03-05 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale+OE | $60.00 | -5,384 | 99.2K | -5% | -$323.0K |
| D | 2025-03-07 | 2025-03-05 | ANIP | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | -300 | 13.2K | -2% | -$9,447 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | M | A | 300 | $31.49 | 99,476 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-05 | S | D | 5,084 | $60.00 | 94,092 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price. |
| 3 | Common | Common Stock | 2025-03-05 | S | D | 300 | $60.03 | 99,176 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-03-05 | M | D | 300 | $31.49 | 13,204 | D | $31.49 · — to 2031-02-15 | 300 Common Stock | (F2) 25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025. |